Compare · PRPO vs RVTY
PRPO vs RVTY
Side-by-side comparison of Precipio Inc. (PRPO) and Revvity Inc. (RVTY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PRPO and RVTY operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- RVTY is the larger of the two at $17.66B, about 397.7x PRPO ($44.4M).
- PRPO has been more active in the news (7 items in the past 4 weeks vs 6 for RVTY).
- RVTY has more recent analyst coverage (24 ratings vs 0 for PRPO).
- Company
- Precipio Inc.
- Revvity Inc.
- Price
- -
- -
- Market cap
- $44.4M
- $17.66B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 7
- 6
- Recent ratings
- 0
- 24
Precipio Inc.
Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test; and ICE-COLD-PCR enables detection of abnormalities in blood samples. The company also operates a cancer diagnostic laboratory located in New Haven, Connecticut. It sells ICE-COLD-PCR technology kits to bio-pharma customers, clinical research, HemeScreen, and COVID-19 antibody tests. The company serves oncologists, hospitals, reference laboratories, physician-office labs, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania. The company is based in New Haven, Connecticut.
Latest PRPO
- SEC Form 10-Q filed by Precipio Inc.
- Precipio Announces Q3-2026 Financial Results
- Precipio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 8-K filed by Precipio Inc.
- Precipio Announces Q3-2026 Shareholder Update Call
- SEC Form 4 filed by Precipio Inc.
- SEC Form 4 filed by Precipio Inc.
- Precipio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Precipio Announces Q2-2026 Financial Results
- Precipio Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Latest RVTY
- SEC Form 10-Q filed by Revvity Inc.
- Revvity upgraded by CFRA
- Revvity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Revvity Announces Financial Results for the Third Quarter of 2026
- Revvity Board Declares Quarterly Dividend
- Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
- Revvity to Present at Upcoming Investor Conferences
- William Blair initiated coverage on Revvity
- Revvity to Host Investor Day
- VP and CAO Gonzales Anita sold $13,060 worth of shares (84 units at $155.48) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 7,117 units (SEC Form 4)